D'Amato Gina, Rocha Lima Caio, Mahany J J, Muro-Cacho Carlos, Haura Eric B
Experimental Therapeutics and Thoracic Oncology Programs, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612-9497, USA.
Lung Cancer. 2004 Jun;44(3):381-90. doi: 10.1016/j.lungcan.2003.11.018.
Neutropenic enterocolitis (NE) is an unusual acute complication of neutropenia, most often associated with leukemia and lymphoma which is characterized by segmental cecal and ascending colon ulceration that may progress to necrosis, perforation, and septicemia. We present a case of neutropenic enterocolitis in a patient with non-small-cell lung cancer who received docetaxel and flavopiridol as part of a phase I clinical trial and review cases in the literature where docetaxel was involved. Given the increased use of docetaxel and other taxanes in the treatment of advanced lung cancer, physicians should be aware of this potential toxicity of therapy.
中性粒细胞减少性小肠结肠炎(NE)是中性粒细胞减少症的一种罕见急性并发症,最常与白血病和淋巴瘤相关,其特征为盲肠和升结肠节段性溃疡,可进展为坏死、穿孔和败血症。我们报告一例非小细胞肺癌患者发生中性粒细胞减少性小肠结肠炎的病例,该患者在一项I期临床试验中接受了多西他赛和黄酮哌啶醇治疗,并回顾了文献中涉及多西他赛的病例。鉴于多西他赛和其他紫杉烷类药物在晚期肺癌治疗中的使用增加,医生应意识到这种潜在的治疗毒性。